This reagent, designated ATF5-CaP-rHDL, significantly reduced the viability and caused apoptotic death of cultured rat C6 glioma cells and patient-derived glioblastoma-initiating cells, but not of cultured astrocytes. Here, ATF5 is linked to central nervous system cancer.